middle.news
Nova Eye Medical Secures Key Approval to Expand Glaucoma Device Sales in China
9:34am on Tuesday 30th of September, 2025 AEST
•
Healthcare
Read Story
Nova Eye Medical Secures Key Approval to Expand Glaucoma Device Sales in China
9:34am on Tuesday 30th of September, 2025 AEST
Key Points
NMPA approval granted for iTrack Advance in China
Established Chinese partner to accelerate market entry
China’s glaucoma patient population over three times larger than the US
Sales growth anticipated from late FY26
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nova Eye Medical (ASX:EYE)
OPEN ARTICLE